Diagnostic ability of Ga-68 PSMA PET to detect dominant and non-dominant tumors, upgrading and adverse pathology in patients with PIRADS 4–5 index lesions undergoing radical prostatectomy-Reference-Cited by-同舟云学术

Diagnostic ability of Ga-68 PSMA PET to detect dominant and non-dominant tumors, upgrading and adverse pathology in patients with PIRADS 4–5 index lesions undergoing radical prostatectomy

Published:2020-08-21 Issue:1 Volume:24 Page:202-209
ISSN:1365-7852
Container-title:Prostate Cancer and Prostatic Diseases
language:en
Short-container-title:Prostate Cancer Prostatic Dis

Author:

Koseoglu Ersin^ORCID,Kordan Yakup,Kilic Mert,Sal Oguzhan^ORCID,Seymen Hulya,Kiremit Murat Can,Armutlu Ayse,Ertoy Baydar Dilek,Altinmakas Emre,Vural Metin,Falay Okan,Canda Abdullah Erdem^ORCID,Balbay Derya,Demirkol Mehmet Onur,Esen Tarik

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Urology,Oncology

Link

https://www.nature.com/articles/s41391-020-00270-8.pdf

Reference31 articles.

1. Mottet N, van den Bergh RCN, Briers E, Cornford P, Santis M, Fanti S, et al. EAU-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer 2020. European Association of Urology Guidelines 2020 edition. Presented at the EAU Annual Congress Amsterdam 2020. European Association of Urology Guidelines Office: Arnhem, The Netherlands; 2020.

2. Esen T, Kilic M, Seymen H, Acar O, Demirkol MO. Can Ga-68 PSMA PET/CT replace conventional imaging modalities for primary lymph node and bone staging of prostate cancer? Eur Urol Focus. 2020;6:218–20.

3. Berger I, Annabattula C, Lewis J, Shetty DV, Kam J, Maclean F. et al. (68)Ga-PSMA PET/CT vs. mpMRI for locoregional prostate cancer staging: correlation with final histopathology. Prostate Cancer Prostatic Dis. 2018;21:204–11.

4. Rhee H, Thomas P, Shepherd B, Gustafson S, Vela I, Russell PJ, et al. Prostate specific membrane antigen positron emission tomography may improve the diagnostic accuracy of multiparametric magnetic resonance imaging in localized prostate cancer. J Urol. 2016;196:1261–7.

5. Demirci E, Kabasakal L, Sahin OE, Akgun E, Gultekin MH, Doganca T, et al. Can SUVmax values of Ga-68-PSMA PET/CT scan predict the clinically significant prostate cancer? Nucl Med Commun. 2019;40:86–91.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate-Specific Membrane Antigen Expression in Patients with Primary Prostate Cancer: Diagnostic and Prognostic Value in Positron Emission Tomography-Prostate-Specific Membrane Antigen;Current Oncology;2024-07-24

2. The role of PSMA PET/CT in predicting downgrading in patients with Gleason score 4+4 prostate cancer in prostate biopsy;World Journal of Urology;2024-05-21

3. Comparisons of mpMRI, 68Ga-PSMA PET/CT and mpMRI combined with 68Ga-PSMA PET/CT in diagnosing prostate cancer based on tumor detection, localization and staging;World Journal of Urology;2024-01-12

4. Head-to-head comparison of prostate-specific membrane antigen PET and multiparametric MRI in the diagnosis of pretreatment patients with prostate cancer: a meta-analysis;European Radiology;2023-11-20

5. Intraoperative Frozen Section via Neurosafe During Robotic Radical Prostatectomy in the Era of Preoperative Risk Stratifications and Primary Staging With mpMRI and PSMA-PET CT: Is There a Perfect Candidate?;Clinical Genitourinary Cancer;2023-10